A medicine may remain clinically unchanged while its commercial relationships change. Transparency should follow material commercial benefit throughout a medicine’s lifecycle. Read the full TSANZ policy proposal here 👉https://buff.ly/AgNZB2K
thoracic.org.au
https://thoracic.org.au/wp-content/uploads/2026/08/TSANZ-Medicines-Supply-Chain-Self-Reporting-Proposal.pdf